Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$5.01 - $7.48 $427,854 - $638,792
-85,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$7.19 - $14.95 $56,491 - $117,462
-7,857 Reduced 8.43%
85,400 $639,000
Q4 2020

Feb 02, 2021

BUY
$6.66 - $14.66 $21,345 - $46,985
3,205 Added 3.56%
93,257 $1.01 Million
Q3 2020

Nov 05, 2020

SELL
$8.69 - $14.47 $40,338 - $67,169
-4,642 Reduced 4.9%
90,052 $796,000
Q2 2020

Aug 12, 2020

BUY
$5.21 - $11.03 $311,021 - $658,457
59,697 Added 170.58%
94,694 $1.01 Million
Q1 2020

May 12, 2020

BUY
$4.46 - $9.2 $28,084 - $57,932
6,297 Added 21.94%
34,997 $208,000
Q4 2019

Jan 27, 2020

BUY
$4.52 - $10.1 $129,723 - $289,870
28,700 New
28,700 $198,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.